INNOVATE
Therapeutic Antibodies
Therapeutic Antibodies project is about developing the use of antibodies as a bioactive molecules by improving their structure, the choice of therapeutic targets and reducing the cost of research and development as well as time-to-market.
This project builds on strong technological skills and knowledge present in Rhône-Alpes region in terms of structural and analytical study of antibody-antigen complex.
The goal is to develop a real technology network to cover the entire value chain of production of a therapeutic antibody.
Technological partners:
European Synchrotron Radiation
Facility, Grenoble
Elspeth GORDON
Industrial Liaison Scientist
Institut de Biologie
Structurale, Grenoble
Anne-Marie DI GUILMI
Researcher
Contact:
Nicolas GROUX
Project manager Therapeutic Antibodies
Phone.: +33 (0)4 37 70 10 12
Email : nicolas.groux@lyonbiopole.com
Lyonbiopole
Bâtiment Domilyon
321, avenue Jean Jaurès
69007 LYON
They speak about...
« By helping academic and industrial partners work more closely together, Lyonbiopole is a true catalyst in the emergence and setup of large-scale innovative R&D projects. iDD biotech has two projects accredited by the cluster (PRAVIC & GLIADYS), which are key steps in the development of an SMB. The cluster’s support, through its professionalism and dynamism, enables us to speed up the development of biotech-based candidate medicines, by integrating a number of technological building blocks that rely on local expertise. This is a means to boost players in various sectors – private or public – by pooling everyone’s expertise and know-how, while making the local and national economy more competitive. »
Claudine Vermot-Desroches
iDD-Biotech - Director of R&D